|
Upfront
By: Jason S. Slakter, M.D.
Diabetic Eye Care: Past, Present, Future
October 2004
Second Opinions
By: George A. Williams, M.D.
Accredited Fellowships: Getting our Priorities Straight
October 2004
Treating Diabetic Eye Disease
Peer-reviewed articles on current standard of care, emerging approaches and clinical trials.
October 2004
Emerging Treatments for Diabetic Eye Disease: Update on Clinical Trials
By: Rajeev Buddi, M.D.; Dean Eliott, M.D.
October 2004
Evolving Treatment Strategies for Diabetic Retinopathy
By: Ron P. Gallemore, M.D., Ph.D.; David S. Boyer, M.D.; Edgar L. Thomas, M.D.
October 2004
Landmark Laser Trials Continue to Govern Standard of Care in Diabetic Retinopathy
October 2004
OCT and FA in Diagnosing and Managing Diabetic Eye Disease
By: Keith Croes; Ellen Kurek
A panel of specialists explain how they utilize both tools in practice.
October 2004
More Retina Specialists Considering ASC Feasibility
By: Stephen C. Sheppard, C.P.A., C.O.E.
Less-involved posterior segment procedures can fit into the environment of a well-run ambulatory surgical center.
October 2004
Do the Advantages of 25-Gauge Vitrectomy Outweigh the Disadvantages?
Our answer varies depending on the case because limitations remain.
October 2004
Lasers for AMD
An at-a-glance guide to today's products.
October 2004
New Products & Services
October 2004
Clinical Trials
October 2004
Imaging
Between AMPPE and Serpiginous Choroidopathy
October 2004
Dear colleague,
By: Dennis P. Han, M.D.
October 2004
The Role of ICG In Macular Hole Surgery
By: Judy E. Kim, M.D.
When an ILM peel is necessary, ICG offers better visibility but must be used with caution.
October 2004
Are You Performing 25-Gauge Vitrectomy?
By: Dennis P. Han, M.D.
These systems offer better patient comfort and shorter opening and closure times.
October 2004
Challenges in Diabetic Vitrectomy
By: Dean Eliott, M.D.
Learn the latest about four issues that affect your outcomes.
October 2004
A Fresh Outlook On Stage 4A ROP
By: Michael T. Trese, M.D.
This diagnosis gives us a new opportunity to provide good vision.
October 2004
Insights From The ETROP Study
By: Michael T. Trese, M.D.
How will this study change your practice?
October 2004
Genetic Screening for Retinoblastoma: Where Do We Stand?
By: William J. Wirostko, M.D.
Although complex, costly, and sometimes unpredictable, testing appropriate candidates can be invaluable.
October 2004
Intraocular Tumor Update: Management of Uveal Melanoma
By: William F. Mieler, M.D.
The COMS and ongoing research offer guidance among the numerous available therapeutic options.
October 2004
Intraocular Sustained Drug Delivery for Retinal Diseases
By: Glenn J. Jaffe, M.D.
Studies show drug delivery implants help us tailor medication to the disease.
October 2004
Relaxing Retinectomy In PVR Surgery
By: Brooks W. McCuen II, M.D.
Learn why this surgeon is doing fewer vitrectomies.
October 2004
The Problem Of New Technology
By: William L. Rich III, M.D.
We all love new technology. So what's the problem? Getting reimbursed. Here is insight from an insider.
October 2004
|
